返回
Scopus Biopharma Inc（SCPS）价格
SCPS 股价走势图
SCPS 收益
Scopus Biopharma Inc
$0
0%
$0
收盘价：Jan 16, 16:00:00 GMT-5
$0
0%
$0
盘后：Jan 16, 20:00:00 GMT-5
关键数据
前收盘价
$0.0004
开盘价
$0.0004
当日区间
$0.0004 - $0.0004
52周范围
$0.0003 - $0.01
交易量
47.0K
平均成交量
2.5K
每股收益（TTM）
-0.32
股息收益率
--
市值
$16.8K
什么是 SCPS？
Scopus Biopharma, Inc. is a biopharmaceutical company, which engages in the development of therapeutics targeting diseases with unmet medical needs. The company is headquartered in New York City, New York and currently employs 13 full-time employees. The company went IPO on 2020-12-16. The firm is developing therapeutics targeting serious diseases with significant unmet medical needs. Its lead development programs are CO-sTiRNA and MRI-1867. Its CO-sTiRNA is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. CO-sTiRNA is a dual-action STAT3 inhibitor. STAT3 is a gene that drives tumor cell growth and anti-tumor immune suppression. CO-sTiRNA also stimulates TLR9 receptors to activate the body’s immune defense to recognize and kill cancer cells. The company is also developing MRI-1867 for the treatment of SSc. SSc is a chronic, systemic autoimmune disease. MRI-1867, is a peripherally-restricted, dual-action cannabinoid-1, or CB1, receptor inverse agonist and inhibitor of inducible nitric oxide synthase, or iNOS.